World Blood Donor Day 2025: This Health Benefit Of Donating Blood Will Surprise You
The theme is also aimed at consolidating support from governments and other stakeholders for investment in efforts for sustained national blood programs that, in turn, ensure universal safe blood transfusion globally.
World Blood Donor Day 2025: History
World Blood Donor Day was established by the WHO with the first celebration of the event in 2004. A year later, in 2005, it was officially recognised as a yearly global event by the 58th World Health Assembly. June 14 was chosen as the date for the annual observance as Austrian physician and biologist Karl Landsteiner, who is regarded as the 'founder" of modern blood transfusion, was born on this very day in 1868.
Among his groundbreaking contributions to modern medical science is the discovery of the ABO blood groups. He also developed the model used to classify blood groups. Landsteiner is also partly credited with the identification of the Rhesus factor.
World Blood Donor Day 2025: Significance
World Blood Donor Day is a significant annual occasion that seeks to honour the compassionate worldview of voluntary blood donors. It also seeks to raise public awareness about the importance of blood donation.
Health Benefits Of Blood Donation
Besides saving the lives of accident victims and patients suffering from life-threatening diseases, blood donation is also believed to have significant health benefits for the donor, including a reduced risk of heart attack. Some research also suggests that donating blood might lower the risk of developing certain cancers.
Blood Donation: A Lifesaving Gift With Health Benefits For Donors Too
According to Dr. Amit Saraf, Director, Internal Medicine at Jupiter Hospital, Thane, blood donation has consistently played a crucial role in modern and historical healthcare systems, supporting a wide range of medical needs—from trauma and emergency care to routine surgeries, cancer treatments, and maternal health services.
Advertisement
'Its value lies not just in emergency situations but also in the continuity of routine medical care," says Dr. Saraf.
Beyond saving lives, regular blood donation offers multiple health benefits to the donors themselves. It can help maintain healthy iron levels, support cardiovascular health, and may encourage the natural regeneration of blood cells.
Additionally, the routine health checks performed before donation can sometimes alert individuals to underlying health conditions, making them more aware of their personal wellbeing.
'There are well-documented health benefits for donors. It's not only about helping others—it helps you know more about your own body too," Dr. Saraf explains.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
Vaccine manufacturers' body, Serum Institute of India reaffirm COVID-19 vaccine safety
The Indian Vaccine Manufacturers Association (IVMA) has assured that all COVID-19 vaccines in India were approved for emergency use authorisation based on extensive evaluation in preclinical studies and human clinical trials. 'Patient safety and product quality are always prioritised during the vaccine development and its manufacture,' Dr G V J A Harshavardhan, Director General, IVMA, said in a statement released on Thursday. The statement sought to reassure the public on the safety and efficacy of COVID-19 vaccines. 'All COVID-19 vaccines in India were approved for emergency use authorisation [restricted use in emergency situations as per World Health Organization guidelines], he said, adding, 'These approvals were based on extensive evaluation in preclinical studies and human clinical trials, with positive results on safety, efficacy, and immunogenicity of these vaccines.' The IVMA statement comes in the backdrop of the Union health ministry saying on Wednesday that extensive studies by several agencies have 'conclusively established no linkages' between COVID-19 vaccines and sudden deaths. The Serum Institute of India also posted on X that the COVID-19 vaccines were safe and scientifically validated. 'Two large-scale studies by ICMR [Indian Council of Medical Research] and AIIMS [All India Institute of Medical Sciences], as cited by the Ministry of Health have found no link between Covid-19 vaccines and sudden deaths,' SII said. The IVMA statement also noted that prior to their release, all COVID-19 vaccines were tested extensively for safety by the manufacturers and were also provided Batch Release Certification by the Central Drugs Laboratory in Kasauli, Himachal Pradesh, under the Ministry of Health and Family Welfare. 'The strengths of innovation and large-scale, high-quality manufacturing are the hallmarks of the Indian vaccine ecosystem. COVID-19 vaccines manufactured in India were largely responsible for not only controlling the COVID-19 pandemic and restricting its impact on lives, livelihoods, but most importantly, enabling India's economic activity and GDP to rebound and grow to new heights globally,' Dr Harshavardhan said. 'This positive impact of COVID-19 vaccination was not only limited to India, but also to several countries worldwide, under the Government of India's Vaccine Maitri programme…,' he added.
News18
2 hours ago
- News18
Brain-Eating Amoeba In Pools And Tanks? What You Should Know This Monsoon
Last Updated: Naegleria fowleri is a free‑living amoeba that thrives in ponds, lakes, slow‑moving rivers, poorly chlorinated swimming pools, and even domestic water storage. Find out more When the monsoon lashes India each year, it leaves behind more than swollen rivers and traffic snarls. Warm, rain‑fed pools and half‑chlorinated overhead tanks become breeding grounds for Naegleria fowleri—the so‑called 'brain‑eating amoeba". The microscopic organism causes primary amoebic meningoencephalitis (PAM), a disease so rare that most doctors never see a case—but so lethal it kills over 95%of those infected. With July 2025 rainfall already above normal in some states, public‑health officials are warning residents to stay vigilant around warm fresh water. Let's understand Naegleria fowleri's ecology, how it shows up in India, and – most importantly – how to stay safe. What Exactly Is Naegleria fowleri? Naegleria fowleri is a free‑living amoeba that thrives in warm fresh water—ponds, lakes, slow‑moving rivers, thermal springs, poorly chlorinated swimming pools, and even domestic water storage. It has three life stages: • Cyst (dormant, resilient to cold) • Trophozoite (feeding form, infectious) • Flagellate (motile form that seeks new environments) Human infection occurs when contaminated water is forced up the nose, typically during swimming, ritual ablution, or vigorous douching. The amoeba travels along the olfactory nerve, crosses the cribriform plate, and attacks brain tissue. Warmer Water Temperatures As per the India Meteorological Data (IMD), average surface temperatures in ponds and reservoirs across the Gangetic plain now hover around 32-34 °C during July—prime conditions for Naegleria fowleri. Urban Water‑Storage Habits Many Indian households store water in rooftop tanks or underground sumps that are rarely cleaned. A 2024 National Centre for Disease Control (NCDC) survey in Delhi and Jaipur found 42% of domestic tanks had free‑chlorine levels below WHO's recommended 0.5 mg/L, creating a safe haven for the amoeba. In Kerala 2023, an 11‑year‑old girl from Alappuzha died after swimming in a canal; lab tests confirmed Naegleria. Last year in Ahmedabad, municipal workers detected the amoeba in an apartment‑complex pool during routine checks; no fatalities, but the episode triggered fresh chlorination rules. In May in Mumbai, a 17‑year‑old boy succumbed at a suburban hospital after using a gym spa pool that tested positive for Naegleria. Although fewer than 20 Indian cases have been confirmed since records began, under‑reporting is likely because PAM symptoms resemble common viral meningitis and diagnostic PCR tests are limited to NIV Pune and a handful of state labs. How Does India Monitor Naegleria? Integrated Disease Surveillance Programme (IDSP): PAM is a notifiable disease since 2022; district hospitals must report suspected cases within 24 hours. Routine Water Sampling: Municipal corporations in major metros now test public pools monthly for free‑chlorine residuals and thermophilic amoebae. Hospital Alerts: NCDC has issued standard operating procedures for early lumbar‑puncture and CSF PCR testing when meningitis does not respond to antibiotics within 24 hours. What's The Treatment? The US Center for Disease Control and Prevention (CDC) recommends an aggressive cocktail of intravenous amphotericin B, rifampicin, fluconazole, azithromycin, and miltefosine, plus targeted hypothermia to reduce brain swelling. India's Directorate General of Health Services (DGHS) imported miltefosine in 2016 after the first Kerala case and stocks it through central medical stores. Still, treatment success worldwide is limited; of more than 430 documented cases, only about 20 survivors exist. Precautions You Should Take Avoid forceful water entry into nose: Don't dive or dunk in warm/standing fresh water. While bathing infants, avoid splashing water up their nostrils. Use chlorinated water for nasal rinses: For neti‑pot or jal‑neti practice, boil water (rolling boil 1 minute) and cool or use distilled/RO water. Maintain domestic tanks & pools: Clean storage tanks every three months; keep free chlorine ≥ 0.5 mg/L. Apartment associations should test pool water weekly in July–September. Public pool etiquette: Check if pool management displays daily chlorine readings. Avoid swimming if water is cloudy or the deck smells musty. Seek immediate care for Meningitis‑like symptoms: If severe headache and fever follow recent swimming, insist on Cerebrospinal Fluid (CSF) testing and mention Naegleria to your doctor. Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : brain-eating amoeba India monsoon Location : New Delhi, India, India First Published: July 03, 2025, 17:05 IST News india Brain-Eating Amoeba In Pools And Tanks? What You Should Know This Monsoon
Indian Express
3 hours ago
- Indian Express
Closing In On TB
Prime Minister Narendra Modi recently reviewed the National Tuberculosis Elimination Programme (NTEP). His emphasis on public participation and scaling up successful and innovative strategies comes at a critical time. Advances in diagnostics, digital tools, and vaccines are creating opportunities to reshape how we detect, treat, and prevent TB. Progress in recent years is encouraging. According to the WHO's 'Global TB Report 2024', global TB incidence fell by 8.3 per cent between 2015 and 2023. India outpaced this trend, achieving a 17.7 per cent reduction. These gains reflect the focused efforts and commitment of the NTEP. As we look to sustain and accelerate these gains, we must focus on closing the diagnostic gap — the most critical weak link in the TB care cascade. In 2023, an estimated 2.7 million people worldwide who developed TB were not diagnosed or notified. Without diagnosis, timely treatment is impossible, and the chain of transmission continues. Compounding this challenge is the emerging evidence that a significant number of TB patients do not exhibit symptoms. Studies suggest that this early stage of the disease, known as subclinical TB, may account for about 50 per cent of cases in high-burden settings, including India. This is likely a key driver of the ongoing transmission. India's recently concluded 100-day intensified TB-Mukt Bharat Abhiyaan has provided several learnings. By screening vulnerable populations, including those without symptoms, the programme noted that the campaign identified 2.85 lakh asymptomatic TB patients — out of 7.19 lakh diagnosed. These individuals would likely have been missed under conventional, symptom-based screening approaches. By deploying portable chest X-rays, the campaign demonstrated the transformative potential of technology. AI-assisted reading of X-rays can detect lung abnormalities rapidly and accurately, allowing for quick identification of otherwise 'missing' cases. The government's plan to scale up this approach country-wide is encouraging and could serve as a global model. A new generation of point-of-care diagnostic tools is transforming what's possible. Traditional sputum-based tests can be challenging, particularly for children and the elderly. But innovations — such as non-invasive sampling methods like tongue or nasal swabs — can help detect TB earlier and more affordably. The availability of open PCR platforms can be another game-changer — by cutting the cost of testing significantly, these platforms can make high-quality molecular diagnostics accessible across public and private settings. In India, several of these tools are already being piloted, and the Indian Council of Medical Research is playing a key role in facilitating their adoption into routine care. Along with the upgradation of our diagnostic capacity, we must look at reducing mortality due to TB. India has taken important steps to improve supportive care, including the doubling of monthly nutritional support under the Nikshay Poshan Yojana (NPY) — a direct cash transfer scheme that helps patients meet their dietary needs during treatment. This expansion is timely, as undernutrition remains one of the leading risk factors for TB progression. The country is also moving toward differentiated models of TB care, where services are tailored based on a patient's risk profile and severity at diagnosis. This includes early risk stratification, timely referral of severe cases to higher-level facilities, and the provision of more intensive inpatient care where needed. This approach can drive down mortality appreciably and must become a core feature of the TB response. We must prioritise reducing TB deaths to as close to zero as possible in the near future. While these advancements in diagnostics, treatment, and care delivery are crucial, we must not lose sight of the long-term solution — an effective TB vaccine. The experience of developing Covid vaccines demonstrates how global collaboration, streamlined regulatory pathways, and strong public investment can significantly accelerate timelines — an approach that must now be applied to TB vaccine development. India, with its scientific leadership and manufacturing capacity, is uniquely placed to drive the development and equitable deployment of next-generation TB vaccines, just as it did with Covid. An mRNA vaccine is in an early stage of development in India, and others are at various stages of clinical trials. PM Modi's leadership has played a pivotal role in keeping TB elimination high on the national agenda and inspiring other countries to set ambitious goals. With continued political commitment, evidence, data-informed policies and a strong focus on innovation, India can drive transformative change in the global fight against TB. The writer is chairperson, MS Swaminathan Research Foundation and principal advisor, NTEP, Ministry of Health and Family Welfare
